Addictive drugs and brain stimulation reward

Annual Review of Neuroscience

Volumn 19, Issue , 1996, Pages 319-340

  Wise, R A ^a  

^a and Applied Physiology   (Canada)

Author keywords

addiction; brain stimulation; opiates; reward; stimulants

Indexed keywords

AMPHETAMINE; APOMORPHINE; BARBITURIC ACID; BENZODIAZEPINE; CAFFEINE; CANNABIS; COCAINE; CYTISINE; DIAMORPHINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENKEPHALIN; MORPHINE; NICOTINE; OPIATE; PHENCYCLIDINE; PSYCHOSTIMULANT AGENT;

ADDICTION; ANIMAL EXPERIMENT; BRAIN DEPTH STIMULATION; DRUG DEPENDENCE; DRUG MECHANISM; ELECTROSTIMULATION; HABITUATION; HYPOTHALAMUS; MEDIAL FOREBRAIN BUNDLE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0029879993     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.ne.19.030196.001535     Document Type: Review

References (203)

1. Bain GT, Kornetsky C. 1987. Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci. 40: 1119-25
2. Bain GT, Kornetsky C. 1989. Ethanol oral self-administration and rewarding brain stimulation. Alcohol 6:499-503
3. Bauco P, Rivest R, Wise RA. 1994. Extracellular nucleus accumbens dopamine and metabolite levels during earned and unearned lateral hypothalamic brain stimulation. Soc. Neurosci. Abstr. 20:823
4. Bauco P, Wang Y, Wise RA. 1992. Cocaine potentiation of lateral hypothalamic brain stimulation reward: a dose response and repeated treatment analysis. Soc. Neurosci. Abstr. 18:1573
5. Bauco P, Wang Y, Wise RA. 1993. Lack of sensitization or tolerance to the facilitating effect of ventral tegmental area morphine on lateral hypothalamic brain stimulation reward. Brain Res. 617:303-8
6. Bauco P, Wise R. 1994. Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol. Exp. Ther. 271:294-301
7. Baxter BL, Gluckman MI, Stein L, Scerni RA. 1974. Self-injection of apomorphine in the rat: positive reinforcement by a dopamine receptor stimulant. Pharmacol. Biochem. Behav. 2:387-91
8. Beninger RJ, Bellisle F, Milner PM. 1977. Schedule control of behavior reinforced by electrical stimulation of the brain. Science 196:547-49
9. Bielajew C, Shizgal P. 1980. Dissociation of the substrates for medial forebrain bundle self-stimulation and stimulation escape using a two-electrode stimulation technique. Physiol. Psychol. 25:707-11
10. Bielajew C, Shizgal P. 1982. Behaviorally derived measures of conduction velocity in the substrate for rewarding medial forebrain bundle stimulation. Brain Res. 237:107-19
11. Bielajew C, Shizgal P. 1986. Evidence implicating descending fibers in self-stimulation of the medial forebrain bundle. J. Neurosci. 6:919-29
12. Bindra D. 1974. A motivational view of learning, performance, and behavior modification. Psychol. Rev. 81:199-213
13. Blaha CD, Phillips AG. 1990. Application of in vivo electrochemistry to the measurement of changes in dopamine release during intracranial self-stimulation. J. Neurosci. Meth. 34:125-33
14. Bower GH, Miller NE. 1958. Rewarding and punishing effects from stimulating the same place in the rat's brain. J. Camp. Physiol. Psychol. 51:69-72
15. Bowyer JF, Spuhler KP, Weiner N. 1984. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther. 229:671-80
16. Bozarth MA. 1987. Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res. 414:77-84
17. Bozarth MA, Gerber GJ, Wise RA. 1980. Intracranial self-stimulation as a technique to study the reward properties of drugs of abuse. Pharmacol. Biochem. Behav. 13 (Suppl. 1):245-47
18. Bozarth MA, Wise RA. 1981. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 28:551-55
19. Broekkamp CLE, Van den Bogaard JH, Heijnen HJ, Rops RH, Cools AR, Van Rossum JM. 1976. Separation of inhibiting and stimulating effects of morphine on self-stimulation behavior by intracerebral microinjections. Eur. J. Pharmacol. 36:443-46
20. Bunney BS, Walters JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185:560-71
21. Carboni E, Imperato A, Perezzani L, Di Chiara G. 1989. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653-61
22. Carlezon WA Jr, Wise RA. 1993a. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res. 620:339-42
23. Carlezon WA Jr, Wise RA. 1993b. Phencyclidine-induced potentiation of brain stimulation reward: Acute effects are not altered by repealed administration. Psychopharmacology 111:402-8
24. Carlezon WA Jr, Wise RA. 1993c. Rats self-administer the non-competitive NMDA receptor antagonists phencyclidine (PCP) and MK-801 directly into the nucleus accumbens. Soc. Neurosci. Abstr. 19:830
25. Carr GD, White NM. 1983. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci. 33:2551-57
26. Carter DA, Phillips AG. 1975. Intracranial self-stimulation at sites in the dorsal medulla oblongata. Brain Res. 94:155-60
27. 9-Tetrahydrocannabinol's enhancement of nucleus accumbens dopamine resembles that of reuptake blockers rather than releasers - evidence from in vivo microdialysis experiments with 3-methoxytyramine. Presented at Annu. Meet. Coll. Prob. Drug Depend., 57th, Palm Beach
28. Church WH, Justice JB Jr, Byrd LD. 1987. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur. J. Pharmacol. 139:345-48
29. Clarke PBS, Hommer DW, Pert A, Skirboll LR. 1985. Electrophysiological actions of nicotine on substantia nigra single units. Br. J. Pharmacol. 85:827-35
30. Clarke PBS, Pert A. 1985. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348:355-58
31. Colle LM, Wise RA. 1988. Effects of nucleus accumbens amphetamine on lateral hypothalamic brain stimulation reward. Brain Res. 459:356-60
32. Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR. 1984. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology 82:6-13
33. Conover KL, Shizgal P. 1994. Competition and summation between rewarding effects of sucrose and lateral hypothalamic stimulation in the rat. Behav. Neurosci. 108:537-48
34. Corbett D, Fox E, Milner PM. 1982. Fiber pathways associated with cerebellar self-stimulation in the rat: a retrograde and anterograde tracing study. Behav. Brain Res. 6:167-84
35. Corbett D, Wise RA. 1979. Intracranial self-stimulation in relation to the ascending noradrenergic fiber systems of the pontine tegmentum and caudal midbrain: a moveable electrode mapping study. Brain Res. 177: 423-36
36. Corbett D, Wise RA. 1980. Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study. Brain Res. 185:1-15
37. Davis WM, Smith SG. 1975. Effect of haloperidol on (+)-amphetamine self-administration. J. Pharm. Pharmacol. 27:540-42
38. Devine DP, Leone P, Pocock D, Wise RA. 1993. Differential involvement of ventral tegmental mu, delta, and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266:1236-46
39. Devine DP, Wise RA. 1994. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14:1978-84
40. De Witte P, Bada MF. 1983. Self-stimulation and alcohol administered orally or intraperitoneally. Exp. Neurol. 82:675-82
41. Di Chiara G, Acquas E, Carboni E. 1991. Role of mesolimbic dopamine in the motivational effects of drugs: brain dialysis and place preference studies. In The Mesolimbic Dopamine System: From Motivation to Aclion, ed. P Willner, J Scheel-Kruger, pp. 367-84. New York: Wiley
42. Di Chiara G, Imperato A. 1988. Drugs of abuse preferentially stimulate dopamine release in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85:5274-78
43. Edmonds DE, Gallistel CR. 1974. Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function. J. Comp. Physiol. Psychol. 87:876-83
44. Einhorn LC, Johansen PA, White FJ. 1988. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 8:100-12
45. Esposito R, Kornetsky C. 1977. Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science 195:189-91
46. Esposito RU, McLean S, Kornetsky C. 1979. Effects of morphine on intracranial self-stimulation to various brain stem loci. Brain Res. 168:425-29
47. Esposito RU, Perry W, Kornetsky C. 1980. Effects of d-amphetamine and naloxone on brain stimulation reward. Psychopharmacology 69:187-91
48. Ettenberg A, Pettit HO, Bloom FE, Koob GF. 1982. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78: 204-9
49. Fibiger HC. 1978. Drugs and reinforcement mechanisms: a critical review of the catecholamine theory. Annu. Rev. Pharmacol. Toxicol. 18:37-56
50. Fibiger HC, LePiane FG, Jakubovic A, Phillips AG. 1987. The role of dopamine in intracranial self-stimulation of the ventral tegmental area. J. Neurosci. 7:3888-96
51. Finlay JM, Damsma G, Fibiger HC. 1992. Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology 106: 202-8
52. Fisher JF, Cho AK. 1979. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208:203-9
53. Fouriezos G, Wise RA. 1976. Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits. Brain Res. 103:377-80
54. Fouriezos G, Wise RA. 1984. Current-distance relation for rewarding brain stimulation. Behav. Brain Res. 14:85-89
55. Frank RA, Manderscheid PZ, Panicker S, Williams HP, Kokoris D. 1992. Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-stimulation reward. Pharmacol. Biochem. Behav. 42:771-79
56. Frank RA, Markou A, Wiggins LL. 1987. A systematic evaluation of the properties of train duration response functions. Behav. Neurosci. 101:546-59
57. Frank RA, Martz S, Pommering T. 1988. The effect of chronic cocaine on self-stimulation train-duration thresholds. Pharmacol. Biochem. Behav. 29:755-58
58. Franklin KBJ. 1978. Catecholamines and self-stimulation: reward and performance effects dissociated. Pharmacol. Biochem. Behav. 9: 813-20
59. Franklin KBJ, McCoy SN. 1979. Pimozide-induced extinction in rats: stimulus control of responding rules out motor deficit. Pharmacol. Biochem. Behav. 11:71-75
60. 10 dopamine neurons in the rat. Neuropharmacology 25:241-48
61. 10 dopamine neurons. Neurosci. Lett. 119:159-62
62. Gallistel CR. 1978. Self-stimulation in the rat: quantitative characteristics of the reward pathway. J. Comp. Physiol. Psychol. 92: 977-98
63. Gallistel CR. 1986. The role of the dopaminergic projections in MFB self-stimulation. Behav. Brain Res. 20:313-21
64. Gallistel CR. 1987. Determining the quantitative characteristics of a reward pathway. In Biological Determinants of Reinforcement, ed. RM Church, ML Commons, JR Stellar, AR Wagner, pp. 1-30. Hillsdale, NJ: Erlbaum Assoc.
65. Gallistel CR, Davis AJ. 1983. Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation. Pharmacol. Biochem. Behav. 19:867-72
66. Gallistel CR, Freyd G. 1987. Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation. Pharmacol. Biochem. Behav. 26:731-41
67. Gallistel CR, Karras D. 1984. Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacol. Biochem. Behav. 20:73-77
68. Gallistel CR, Shizgal P, Yeomans J. 1981. A portrait of the substrate for self-stimulation. Psychol. Rev. 88:228-73
69. Gallistel CR, Stellar JR, Bubis E 1974. Parametric analysis of brain stimulation reward in the rat: 1. The transient process and the memory-containing process. J. Comp. Physiol. Psychol. 87:848-59
70. Gardner EL. 1992. Brain reward mechanisms. In Substance Abuse: A Comprehensive Textbook, ed. JH Lowinson, P Ruiz, RB Millman, pp. 70-99. Baltimore: Williams & Wilkins
71. 9-tetrahydrocannabinol. Psychopharmacology 96:142-44
72. 9tetrahydrocannabinol is mediated by an endogenous opioid mechanism. Adv. Biosci. 75:671-74
73. Gerhardt GA, Pang K, Rose GM. 1987. In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus. J. Pharmacol. Exp. Ther. 241:714-21
74. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G. 1985. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348:201-4
75. Goeders NE, Lane JD, Smith JE. 1984. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20:451-55
76. Goeders NE, Smith JE. 1983. Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773-75
77. Goeders NE, Smith JE. 1993. Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens. J. Pharmacol. Exp. Ther. 265:592-600
78. Govoni S, Petkov VV, Montefusco O, Missale C, Battaini F, et al. 1984. Differential effects of caffeine on dihydroxyphenylacetic concentrations in various rat brain regions. J. Pharm. Pharmacol. 36:458-60
79. Gratton A, Hoffer BJ, Gerhardt GA. 1988. Effects of electrical stimulation of brain reward sites on release of dopamine in rat: an in vivo electrochemical study. Brain Res. Bull. 21: 319-24
80. Grenhoff J, Aston-Jones G, Svensson TH. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand. 128:351-58
81. Heath RG. 1963. Intracranial self-stimulation in man. Science 140:394-96
82. Heath RG. 1972. Pleasure and brain activity in man. J. Nerv. Ment. Dis. 154:3-18
83. Heath RG. 1975. Brain function and behavior. I. Emotion and sensory phenomena in psychotic patients and in experimental animals. J. Nerv. Ment. Dis. 160:159-75
84. 3H)dopamine in rat brain tissue slices. Biochem. Pharmacol. 24: 847-52
85. 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J. Pharmacol. Exp. Ther. 194:47-56
86. Hernandez L, Auerbach S, Hoebel BG. 1988. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Life Sci. 42:1713-23
87. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L. 1983. Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158-63
88. Hubner CB, Bird M, Rassnick S, Kornetsky C. 1988. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology 95:49-51
89. Hubner CB, Koob GF. 1990. The ventral striatum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res. 508:20-29
90. Hubner CB, Kornetsky C. 1992. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation. J. Pharmacol. Exp. Ther. 260: 562-67
91. Hurd YL, Kehr J, Ungerstedt U. 1988. In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J. Neurochem. 51:1314-16
92. 2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur. J. Pharmacol. 166:261-69
93. Hurd YL, Ungerstedt U. 1989b. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3:48-54
94. Huston-Lyons DJ, Bain GT, Kornetsky C. 1992. The effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol. Biochem. Behav. 41:755-59
95. Jenck F, Gratton A, Wise RA. 1987. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward. Brain Res. 423:34-38
96. Johanson CE. 1978. Drugs as reinforcers. In Contemporary Research in Behavioral Pharmacology, ed. DE Blackman, DJ Sanger, pp. 325-90. New York: Plenum
97. Johnson SW, North RA. 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:483-88
98. Josefsson J-O, Johansson P. 1979. Naloxone-reversible effect of opioids on pinocytosis in Amoeba proteus. Nature 282:78-80
99. Kavaliers M, Hirst M. 1987. Slugs and snails and opiate tales: opioids and feeding behavior in invertebrates. Fed. Proc. 46:168-72
100. Keesey RE. 1962. The relation between pulse frequency, intensity, and duration and the rate of responding for intracranial stimulation. J. Comp. Physiol. Psychol. 55:671-78
101. Kent E, Grossman SP. 1969. Evidence for a conflict interpretation of anomalous effects of rewarding brain stimulation. J. Comp. Physiol. Psychol. 69:381-90
102. Koob GF. 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:177-84
103. Kornetsky C, Esposito RU. 1979. Euphorigenic drugs: effects on the reward pathways of the brain. Fed. Proc. 38:2473-76
104. Kornetsky C, Esposito RU. 1981. Reward and detection thresholds for brain stimulation: dissociative effects of cocaine. Brain Res. 209:496-500
105. Leith NJ. 1983. The effects of apomorphine on self-stimulation responding: Does the drug mimic the current? Brain Res. 277:129-36
106. Lepore M, Franklin KBJ. 1992. Modelling drug kinetics with brain stimulation: Dopamine antagonists increase self-stimulation. Pharmacol. Biochem. Behav. 41:489-96
107. Liebman JM. 1983. Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci. Biobehav. Rev. 7:45-72
108. Liebman JM, Butcher LL. 1974. Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substantia nigra, lateral hypothalamus, and mesencephalic central gray. Naunyn-Schmiedeberg's Arch. Pharmacol. 284:167-94
109. Lippa AS, Antelman SM, Fisher AE, Canfield DR. 1973. Neurochemical mediation of reward: a significant role for dopamine. Pharmacol. Biochem. Behav. 1:23-28
110. Lyness WH, Friedle NM, Moore KE. 1979. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol. Biochem. Behav. 11:553-56
111. Marcus R, Kornetsky C. 1974. Negative and positive intracranial reinforcement thresholds: effects of morphine. Psychopharmacologia 38:1-13
112. Martin-Iverson MT, Szostak C, Fibiger HC. 1986. 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacology 88:310-14
113. Mereu G, Yoon K-WP, Boi V, Gessa GL, Naes L, Westfall TC. 1987. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur. J. Pharmacol. 141: 395-400
114. Miliaressis E, Rompre P-P, Laviolette LP, Philippe L, Coulombe D. 1986. The curve-shift paradigm in self-stimulation. Physiol. Behav. 37:85-91
115. Moolten M, Kornetsky C. 1990. Oral self-administration of ethanol and not experimenter-administered ethanol facilitates rewarding electrical brain stimulation. Alcohol 7:221-25
116. Mumford GK, Neill DB, Holtzman SG. 1988. Caffeine elevates reinforcement threshold for electrical brain stimulation: tolerance and withdrawal changes. Brain Res. 459: 163-67
117. Museo E, Wise RA. 1994. Place preference conditioning with ventral tegmental injections of cytisine. Life Sci. 55:1179-86
118. Nazzaro JM, Seeger TF, Gardner EL. 1981. Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol. Biochem. Behav. 14: 325-31
119. Nomikos GG, Damsma G, Wenkstern BA, Fibiger HC. 1990. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6:106-12
120. Olds J. 1956. Pleasure centers in the brain. Sci. Am. 195:105-16
121. Olds J. 1958. Self-stimulation of the brain. Science 127:315-24
122. Olds J, Allan WS, Briese E. 1971. Differentiation of hypothalamic drive and reward centers. Am. J. Physiol. 221:368-75
123. Olds J, Milner PM. 1954. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47:419-27
124. Olds J, Olds ME. 1965. Drives, rewards, and the brain. In New Directions in Psychology, ed. TM Newcombe, pp. 327-410. New York: Holt, Rinehart & Winston
125. Olds ME. 1982. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237:429-40
126. Olds ME, Olds J. 1963. Approach-avoidance analysis of rat diencephalon. J. Comp. Neurol. 120:259-95
127. Pavlov IP. 1927. Conditioned Reflexes. Oxford: Oxford Univ. Press
128. Pfaus JG, Phillips AG. 1990. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats. Psychopharmacology 98:363-68
129. Phillips AG. 1970. Enhancement and inhibition of olfactory bulb self-stimulation by odours. Physiol. Behav. 5:1127-31
130. Phillips AG. 1984. Brain reward circuitry: a case for separate systems. Brain. Res. Bull. 12:195-201
131. Phillips AG, Broekkamp CLE, Fibiger HC. 1983. Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 7:585-90
132. Phillips AG, Fibiger HC. 1978. The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex. Can. J. Psychol. 32:58-66
133. Phillips AG, LePiane FG. 1980. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol. Biochem. Behav. 12:965-68
134. Prado-Alcala R, Streather A, Wise RA. 1984. Brain stimulation reward and dopamine terminal fields. II. Septal and cortical projections. Brain Res. 301:209-19
135. Prado-Alcala R, Wise RA. 1984. Brain stimulation reward and dopamine terminal fields. I. Caudate-putamen, nucleus accumbens and amygdala. Brain Res. 297:265-73
136. Rassnick S, Pulvirenti L, Koob GF. 1992. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology 109:92-98
137. Reid AA, Monn JA, Jacobson AE, Rice KC, Rothman RB. 1990. Pseudoallosteric modulation by (+)-MK-801 of NMDA-coupled phencyclidine binding sites. Life Sci. 46: PL77-PL82
138. Risner ME, Jones BE. 1976. Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacol. Biochem. Behav. 5:477-82
139. Roberts DCS, Corcoran ME, Fibiger HC. 1977. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6: 615-20
140. Roberts DCS, Koob GF, Klonoff P, Fibiger HC. 1980. Extinction and recovery of cocaine self-administration following 6-OHDA lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:781-87
141. Roberts WW. 1958. Both rewarding and punishing effects from stimulation of posterior hypothalamus of cat with same electrode at same intensity. J. Comp. Physiol. Psychol. 51:400-7
142. Robertson GS, Damsma G, Fibiger HC. 1991. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 7:2209-16
143. Rompré P-P. 1987. Effects of concomitant motor reactions on the measurement of rewarding efficacy of brain stimulation. Behav. Neurosci. 101:827-31
144. Rompré P-P, Wise RA. 1989. Opioid-neuroleptic interaction in brain stem self-stimulation. Brain Res. 477:144-51
145. Samson HH, Hodge CW, Tolliver GA, Haraguchi M. 1993. Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens. Brain Res. Bull. 30:133-41
146. Schaefer GJ, Holtzman SG. 1979. Free-operant and auto-titration brain self-stimulation procedures in the rat: a comparison of drug effects. Pharmacol. Biochem. Behav. 10: 127-35
147. Schaefer GJ, Michael RP. 1987. Ethanol and current thresholds for brain self-stimulation in the lateral hypothalamus of the rat. Alcohol 4:209-13
148. Schaefer GJ, Michael RP. 1988. An analysis of the effects of amphetamine on brain self-stimulation behavior. Behav. Brain Res. 29: 93-101
149. Seeger TF, Carlson KR, Nazarro JM. 1981. Pentobarbitol induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold. Pharmacol. Biochem. Behav. 15: 583-86
150. Sesack SR, Aoke C, Pickel VM. 1994. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14:88-106
151. Shizgal P, Bielajew C, Corbett D, Skelton R, Yeomans J. 1980. Behavioral methods for inferring anatomical linkage between rewarding brain stimulation sites. J. Comp. Physiol. Psychol. 94:227-37
152. Siegel R. 1989. Intoxication: Life in Pursuit of Artificial Paradise. New York: Dutton
153. Simon H, LeMoal M, Cardo B. 1975. Self-stimulation in the dorsal pontine tegmentum in the rat. Behav. Biol. 13:339-47
154. Skelton RW, Shizgal P. 1980. Parametric analysis of ON- and OFF- responding for hypothalamic stimulation. Physiol. Behav. 25:699-706
155. Skinner BF. 1937. Two types of conditioned reflex: a reply to Konorski and Miller. J. Gen. Psychol. 16:272-79
156. Skinner BF. 1938. The Behavior of Organisms. New York: Appleton-Century-Crofts
157. Skinner BF. 1950. Are theories of learning necessary? Psychol. Rev. 57:193-216
158. Spealman RD, Goldberg SR. 1978. Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu. Rev. Pharmacol. Toxicol. 18:313-39
159. St-Laurent J. 1988. Behavioral correlates of self-stimulation, flight and ambivalence. Brain Res. Bull. 21:61-77
160. Stein L. 1968. Chemistry of reward and punishment. In Proceedings of the American College of Neuropsychopharmacology, ed. DH Efron, pp. 105-23. Washington, DC: US Gov. Print. Off.
161. Stein L, Ray OS. 1960. Brain stimulation reward "thresholds" self-determined in rat. Psychopharmacology 1:251-56
162. Szostak C, Finlay JM, Fibiger HC. 1987. Intravenous self-administration of the short-acting benzodiazepine midazolam in the rat. Neuropharmacology 26:1673-76
163. Thompson T. 1968. Drugs as reinforcers: experimental addiction. Int. J. Addict. 3:199-206
164. Thorndike EL. 1898. Animal intelligence: an experimental study of the associative processes in animals. Psychol. Monogr. 8:1-109
165. Thorndike EL. 1933. A theory of the action of the after-effects of a connection upon it. Psychol. Rev. 40:434-39
166. Trowill JA, Panksepp J, Gandelman R. 1969. An incentive model of rewarding brain stimulation. Psychol. Rev. 76:264-81
167. Valenstein ES. 1964. Problems of measurement with reinforcing brain stimulation. Psychol. Rev. 71:415-37
168. van der Kooy D, Mucha RF, O'Shaughnessy M, Bucenieks P. 1982. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res. 243:107-17
169. van der Kooy D, Phillips AG. 1977. Trigeminal substrates of intracranial self-stimulation. Science 196:447-49
170. van Ree JM, de Wied D. 1980. Involvement of neurohypophyseal peptides in drug-mediated adaptive responses. Pharmacol. Biochem. Behav. 13(Suppl. 1):257-63
171. Welzl H, Kuhn G, Huston JP. 1989. Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat. Neuropharmacology 28:1017-23
172. West TEG, Wise RA. 1988a. Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions. Brain Res. 462: 126-33
173. West TEG, Wise RA. 1988b. Nucleus accumbens opioids facilitate brain stimulation reward. Soc. Neurosci. Abstr. 14:1102
174. Westerink BHC, Tuntler J, Damsma G, Rollema H, De Vries JB. 1987. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:502-7
175. Wise RA. 1972. Spread of current from monopolar stimulation of the lateral hypothalamus. Am. J. Physiol. 223:545-48
176. Wise RA. 1978. Catecholamine theories of reward: a critical review. Brain Res. 152:215-47
177. Wise RA. 1980a. The dopamine synapse and the notion of "pleasure centers" in the brain. Trends Neurosci. 3:91-94
178. Wise RA. 1980b. Action of drugs of abuse on brain reward systems. Pharmacol. Biochem. Behav. 13:213-23
179. Wise RA. 1981. Intracranial self-stimulation: mapping against the lateral boundaries of the dopaminergic cells of the substantia nigra. Brain Res. 213:190-94
180. Wise RA. 1982. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav. Brain Sci. 5:39-87
181. Wise RA. 1985. The anhedonia hypothesis: mark III. Behav. Brain Sci. 8:178-86
182. Wise RA. 1987. Intravenous drug self-administration: a special case of positive reinforcement. In Methods of Assessing the Reinforcing Properties of Abused Drugs, ed. MA Bozarth, pp. 117-41. New York: Springer-Verlag
183. Wise RA. 1989. The brain and reward. In The Neuropharmacological Basis of Reward, ed. JM Liebman, SJ Cooper, pp. 377-424. Oxford: Oxford Univ. Press
184. Wise RA, Bauco P, Carlezon WA Jr, Trojniar W. 1992. Self-stimulation and drug reward mechanisms. Ann. NY Acad Sci. 654:192-98
185. Wise RA, Bozarth MA. 1984. Brain reward circuitry: four circuit elements "wired" in apparent series. Brain Res. Bull. 12:203-8
186. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:469-92
187. Wise RA, Carlezon WA Jr. 1994. Self-administration of the dopamine uptake inhibitor nomifensine into nucleus accumbens of rats. Presented at Annu Meet. Coll. Prob. Drug Depend., 57th, Palm Beach
188. Wise RA, Munn E. 1993. Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion. Behav. Brain Res. 55: 195-201
189. Wise RA, Rompré P-P. 1989. Brain dopamine and reward. Annu. Rev. Psychol. 40:191-225
190. Wood PL. 1982. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat. J. Pharmacol. Exp. Ther. 222:674-79
191. Woods JH, Schuster CR. 1971. Opiates as reinforcing stimuli. In Stimulus Properties of Drugs, ed. T Thompson, R Pickens, pp. 163-75. New York: Appleton-Century-Crofts
192. Yeomans JS. 1979. Absolute refractory periods of self-stimulation neurons. Physiol. Behav. 22:911-19
193. Yeomans JS. 1982. The cells and axons mediating medial forebrain bundle reward. In The Neural Basis of Feeding and Reward, ed. BG Hoebel, D Novin, pp. 405-17. Brunswick, ME: Haer Inst.
194. Yeomans JS. 1989. Two substrates for medial forebrain bundle self-stimulation: myelinated axons and dopamine axons. Neurosci. Biobehav. Rev. 13:91-98
195. Yeomans JS, Maidment NT, Bunney BS. 1988. Excitability properties of medial forebrain bundle axons of A9 and A10 dopamine cells. Brain Res. 450:86-93
196. Yeomans JS, Mathur A, Tampakeras M. 1993. Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav. Neurosci. 107: 1077-87
197. Yeomans JS, Mercouris N, Ellard C. 1985. Behaviorally measured refractory periods are lengthened by reducing electrode tip exposure or raising current. Behav. Neurosci. 99: 913-28
198. Yokel RA, Wise RA. 1975. Increased lever-pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547-49
199. Yokel RA, Wise RA. 1976. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311-18
200. Zarevics P, Setler P. 1979. Simultaneous rate-independent and rate-dependent assessment of intracranial self-stimulation: evidence for the direct involvement of dopamine in brain reinforcement mechanisms. Brain Res. 169: 499-512
201. Zetterström T, Herrera-Marschitz U, Ungerstedt U. 1981. Simultaneous estimation of dopamine release and rotational behaviour induced by d-amphetamine in 6-OH-DA denervated rats. Neurosci. Lett. 7:27-32 (Suppl.)
202. Zetterström T, Sharp T, Collin AK, Ungerstedt U. 1988. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:327-34
203. Zito KA, Vickers G, Roberts DCS. 1985. Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 25:1029-36